John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD

Slides:

Advertisements

Similar presentations

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Advertisements

Neutron radiation therapy for advanced thyroid cancers Tobias R. Chapman, MD, George E. Laramore, PhD, MD, Stephen R. Bowen, PhD, Peter F. Orio, DO, MS.

Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate.

A Hole in the Heart Journal of Thoracic Oncology

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes Stuart E. Samuels, MD, PhD, Matthew.

Pathologic response after neoadjuvant chemotherapy predicts locoregional control in patients with triple negative breast cancer Victor E. Chen, BS, Erin.

Colloquium on Therapy of Right Heart Failure

Management of independent motion between multiple targets in lung cancer radiation therapy Feng Liu, PhD, An Tai, PhD, Ergun Ahunbay, PhD, Elizabeth.

Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From.

Abscopal effect in recurrent colorectal cancer treated with carbon-ion radiation therapy: 2 case reports Daniel K. Ebner, BS, Tadashi Kamada, MD, PhD,

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity Sarah J. Stephens, MD, Samantha Thomas, MB,

Sociodemographic disparities in the utilization of proton therapy for prostate cancer at an urban academic center Kristina D. Woodhouse, MD, Wei-Ting.

Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy Fady F. Youssef, MS, Parag.

Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy Dawn Owen, MD, PhD, Charles S. Mayo, PhD,

Risk of carotid blowout after reirradiation with particle therapy

Detection of regional radiation-induced lung injury using hyperpolarized 129Xe chemical shift imaging in a rat model involving partial lung irradiation:

Detection of late radiation damage on left atrial fibrosis using cardiac late gadolinium enhancement magnetic resonance imaging Y. Jessica Huang, PhD,

Reducing radiation dose and enhancing imaging quality of 4DCT for radiation therapy using iterative reconstruction algorithms George Noid, PhD, An Tai,

Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial Susanne M.

Effect of variations in atelectasis on tumor displacement during radiation therapy for locally advanced lung cancer Nathan Tennyson, MD, Elisabeth Weiss,

A phase 2 trial of salvage radiation and concurrent weekly docetaxel after a rising prostate-specific antigen level after radical prostatectomy William.

Long-term outcomes of dose-escalated intensity modulated radiation therapy alone without androgen deprivation therapy for patients with intermediate and.

Tijana Skrepnik, MD, Silvija Gottesman, MD, Baldassarre Stea, MD, PhD

The Lung Cancer Stage Page

Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity.

Prospective Study of Patient-Reported Symptom Burden in Patients With Non–Small- Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy Xin.

Volume 61, Issue 1, Pages (January 2012)

Jennifer C. Ho, MD, Quynh-Nhu Nguyen, MD, Heng Li, PhD, Pamela K

SC17.02 Lung Cancer in China: Challenges and Perspectives

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Postoperative Proton Therapy in the Management of Stage III Thymoma

Effect of bra use during radiation therapy for large-breasted women: Acute toxicity and treated heart and lung volumes Lanea M.M. Keller, MD, MS, Randi.

Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non–Small Cell Lung Cancer Christina K. Speirs, MD, PhD, Todd.

Safety of differential radiation dosing in lymph node positive necks treated with IMRT Stephen Sozio, MBS, Zorimar Rivera-Núñez, PhD, Omar Mahmoud, MD,

My Path from Hiroshima to Houston

Dosimetric comparison of 3-dimensional conformal radiation therapy and intensity modulated radiation therapy and impact of setup errors in lower limb.

Results of a Multicentric In Silico Clinical Trial (ROCOCO): Comparing Radiotherapy with Photons and Protons for Non-small Cell Lung Cancer Erik Roelofs,

Electronic Updates for JTO Readers

Hedgehog Signaling Pathway and Lung Cancer

Intensity modulated radiation therapy after radical prostatectomy: Early results show no decline in urinary continence, gastrointestinal, or sexual quality.

Phantom Verification of AAA and Acuros Dose Calculations for Lung Cancer: Do Tumor Size and Regression Matter? Satomi Shiraishi, PhD, Luis E. Fong de.

Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.

Stereotactic body radiation therapy and 3-dimensional conformal radiotherapy for stage I non-small cell lung cancer: A pooled analysis of biological equivalent.

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Technical Advances of Radiation Therapy for Thymic Malignancies

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

ITV-Based Robust Optimization for VMAT Planning of Stereotactic Body Radiation Therapy of Lung Cancer Xiaoying Liang, PhD, Dandan Zheng, PhD, Maria Mamalui-Hunter,

Defining Optimal Comorbidity Measures for Patients With Early-Stage Non-small cell lung cancer Treated With Stereotactic Body Radiation Therapy Todd.

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

A Hole in the Heart Journal of Thoracic Oncology

An Editorial Note: The Long Arm of Practical Radiation Oncology

Burnout and Resiliency in Canadian Oncology Residents: A Nationwide Resident and Program Director Survey Hannah Dahn, MD, Angela McGibbon, MD, David.

Volume 9, Issue 8, Pages S14-S17 (August 2012)

Safety considerations for IMRT: Executive summary

Erratum The American Journal of Human Genetics

Ayman O. Soubani, MD, John C. Ruckdeschel, MD

Hemithoracic Radiotherapy After Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma: A Dosimetric Comparison of Two Well-Described Techniques

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most? Georgios Ntentas, DPhil, Katerina Dedeckova, MD, Michal.

Changing practice patterns for breast cancer radiation therapy with clinical pathways: An analysis of hypofractionation in a large, integrated cancer.

A Phase I Study of Gefitinib with Concurrent Dose-Escalated Weekly Docetaxel and Conformal Three-Dimensional Thoracic Radiation Followed by Consolidative.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Gregory G. Ginsberg, MD Gastrointestinal Endoscopy

Cardiovascular surgery—The rocket and its stars: Presidential address

740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells Molecular Therapy Volume 20, Pages S285-S286.

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Formation of a Bronchoesophageal Fistula Following Concurrent Radiation and Chemotherapy for Lung Cancer in the Setting of Behçet's Disease Jeffrey Meyer,

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Induction Therapy For Locally Advanced Thymoma

A Review of First-Line Treatment for Small-cell Lung Cancer

Presentation transcript:

Dosimetric advantages of intensity modulated radiation therapy in locally advanced lung cancer John Boyle, MD, Brad Ackerson, MD, Lin Gu, MS, Chris R. Kelsey, MD Advances in Radiation Oncology Volume 2, Issue 1, Pages 6-11 (January 2017) DOI: 10.1016/j.adro.2016.12.006 Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

Figure 1 Distribution and comparison of lung V20 Gy for intensity modulated radiation therapy (IMRT) and 3-dimensional conformal radiation (3D-CRT) plans. Advances in Radiation Oncology 2017 2, 6-11DOI: (10.1016/j.adro.2016.12.006) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

Figure 2 Distribution and comparison of esophagus V60 Gy for IMRT and 3D-CRT plans. See Fig 1 for abbreviations. Advances in Radiation Oncology 2017 2, 6-11DOI: (10.1016/j.adro.2016.12.006) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions

Figure 3 Distribution and comparison of heart V5 Gy for IMRT and 3D-CRT plans. See Fig 1 for abbreviations. Advances in Radiation Oncology 2017 2, 6-11DOI: (10.1016/j.adro.2016.12.006) Copyright © 2016 The Authors on behalf of the American Society for Radiation Oncology Terms and Conditions